WATERTOWN, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
J. Cole recounts the difficult recording process of his new single Disc 2, Track 2. On Tuesday (Jan. 20), music journalist Timmhotep Aku shared a portion of a recent interview he conducted with the ...
BioRestorative Therapies, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its BRTX-100 program for treating chronic lumbar disc disease (cLDD).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results